Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetronine for children undergoing cardiopulmonary bypass
NCT02222532Phase 3Completed
- Sponsor
- National Cardiovascular Center Harapan Kita
- Start
- Jun 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tetronine in congenital heart disease (CHD), sponsored by National Cardiovascular Center Harapan Kita. Started Jun 2013; status: completed.
02
Drugs
Tetronine
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT02222532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02222532.